期刊论文详细信息
JOURNAL OF CONTROLLED RELEASE 卷:159
Peptides in cancer nanomedicine: Drug carriers, targeting ligands and protease substrates
Review
Chen, Xiaoyuan1 
[1] NIBIB, LOMIN, NIH, Intramural Res Program, Bethesda, MD 20892 USA
关键词: Peptides;    Cancer;    Nanomedicine;    Drug delivery;    Tumor targeting;    Protease-responsive;   
DOI  :  10.1016/j.jconrel.2011.10.023
来源: Elsevier
PDF
【 摘 要 】

Peptides are attracting increasing attention as therapeutic agents, as the technologies for peptide development and manufacture continue to mature. Concurrently, with booming research in nanotechnology for biomedical applications, peptides have been studied as an important class of components in nanomedicine, and they have been used either alone or in combination with nanomaterials of every reported composition. Peptides possess many advantages, such as smallness, ease of synthesis and modification, and good biocompatibility. Their functions in cancer nanomedicine, discussed in this review, include serving as drug carriers, as targeting ligands, and as protease-responsive substrates for drug delivery. Published by Elsevier B.V.

【 授权许可】

Free   

【 预 览 】
附件列表
Files Size Format View
10_1016_j_jconrel_2011_10_023.pdf 900KB PDF download
  文献评价指标  
  下载次数:3次 浏览次数:0次